HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Javier Casado Selected Research

Nucleoside Transport Proteins (Nucleoside Transporter)

12/2008Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
8/2008Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.
1/2006Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.
10/2003Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Javier Casado Research Topics

Disease

8Neoplasms (Cancer)
09/2012 - 10/2003
4Breast Neoplasms (Breast Cancer)
09/2012 - 01/2006
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2008 - 03/2003
3Hepatocellular Carcinoma (Hepatoma)
04/2006 - 04/2004
2Adenocarcinoma
08/2008 - 10/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2008 - 10/2003
2Infections
01/2006 - 02/2005
1Colonic Neoplasms (Colon Cancer)
09/2012
1Vascular Diseases (Vascular Disease)
10/2009
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2006
1Ovarian Neoplasms (Ovarian Cancer)
12/2004
1Carcinoma (Carcinomatosis)
12/2004
1Shock
07/2003
1Starvation
07/2003
1Leukemia
03/2003
1Hematologic Neoplasms (Hematological Malignancy)
03/2003

Drug/Important Bio-Agent (IBA)

12NucleosidesIBA
09/2012 - 03/2003
8Pharmaceutical PreparationsIBA
09/2012 - 03/2003
5Proteins (Proteins, Gene)FDA Link
10/2009 - 03/2003
4GemcitabineFDA Link
09/2012 - 10/2003
4Nucleoside Transport Proteins (Nucleoside Transporter)IBA
12/2008 - 10/2003
3Messenger RNA (mRNA)IBA
09/2012 - 07/2003
3Protein Isoforms (Isoforms)IBA
06/2008 - 10/2003
2Capecitabine (Xeloda)FDA Link
09/2012 - 12/2006
2doxifluridineIBA
09/2012 - 12/2006
2fludarabineIBA
12/2008 - 03/2003
2Equilibrative Nucleoside Transporter 1IBA
08/2008 - 07/2006
1Aquaporin 3IBA
09/2012
1AquaglyceroporinsIBA
09/2012
1Dipyridamole (Persantine)FDA LinkGeneric
10/2009
1DilazepIBA
10/2009
1Antineoplastic Agents (Antineoplastics)IBA
08/2008
1Complement System Proteins (Complement)IBA
02/2008
1ProdrugsIBA
12/2006
1Fluorouracil (Carac)FDA LinkGeneric
12/2006
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2006
1Adenosine Triphosphate (ATP)IBA
04/2006
1Bile Acids and Salts (Bile Acids)IBA
04/2006
1Biomarkers (Surrogate Marker)IBA
01/2006
1Reverse Transcriptase InhibitorsIBA
01/2006
1EnzymesIBA
02/2005
1Immune Sera (Antisera)IBA
12/2004
1AntibodiesIBA
12/2004
1ParaffinIBA
12/2004
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
10/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2004
1Interleukin-6 (Interleukin 6)IBA
10/2004
1adenosine transporterIBA
04/2004
1Carrier Proteins (Binding Protein)IBA
10/2003
1Amino AcidsFDA Link
07/2003
1Pharmacologic ActionsIBA
03/2003

Therapy/Procedure

2Drug Therapy (Chemotherapy)
09/2012 - 01/2006